BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25471680)

  • 1. Pioglitazone inhibits advanced glycation end product-induced TNF-α and MMP-13 expression via the antagonism of NF-κB activation in chondrocytes.
    Chen C; Ma C; Zhang Y; Zeng Y; Li Y; Wang W
    Pharmacology; 2014; 94(5-6):265-72. PubMed ID: 25471680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
    Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
    Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of PPARγ in Advanced Glycation End Products-Induced Inflammatory Response in Human Chondrocytes.
    Ma C; Zhang Y; Li YQ; Chen C; Cai W; Zeng YL
    PLoS One; 2015; 10(5):e0125776. PubMed ID: 26024533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-κB.
    Zhang HB; Zhang Y; Chen C; Li YQ; Ma C; Wang ZJ
    Apoptosis; 2016 Oct; 21(10):1082-93. PubMed ID: 27515513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition effect of curcumin on TNF-α and MMP-13 expression induced by advanced glycation end products in chondrocytes.
    Yang Q; Wu S; Mao X; Wang W; Tai H
    Pharmacology; 2013; 91(1-2):77-85. PubMed ID: 23183190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PPARα in down-regulating AGE-induced TGF-β and MMP-9 expressions in chondrocytes.
    Wang J; Wang G; Sun GW
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
    Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
    J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products.
    Chen YJ; Sheu ML; Tsai KS; Yang RS; Liu SH
    PLoS One; 2013; 8(6):e66611. PubMed ID: 23776688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes.
    Nah SS; Choi IY; Yoo B; Kim YG; Moon HB; Lee CK
    FEBS Lett; 2007 May; 581(9):1928-32. PubMed ID: 17434489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a rabbit model to study the influence of advanced glycation end products accumulation on osteoarthritis and the protective effect of pioglitazone.
    Li Y; Zhang Y; Chen C; Zhang H; Ma C; Xia Y
    Osteoarthritis Cartilage; 2016 Feb; 24(2):307-14. PubMed ID: 26321377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells.
    Yuan X; Liu N
    J Genet Genomics; 2011 May; 38(5):193-200. PubMed ID: 21621740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
    Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
    Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
    Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
    Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways.
    Boileau C; Martel-Pelletier J; Fahmi H; Mineau F; Boily M; Pelletier JP
    Arthritis Rheum; 2007 Jul; 56(7):2288-98. PubMed ID: 17599749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Function of PPARγ/AMPK/SIRT-1 Pathway in Inflammatory Response of Human Articular Chondrocytes Stimulated by Advanced Glycation End Products.
    Huang H; Wang ZJ; Zhang HB; Liang JX; Cao WD; Wu Q; He CP; Chen C
    Biol Pharm Bull; 2019; 42(8):1303-1309. PubMed ID: 31366866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.
    Huang CY; Lai KY; Hung LF; Wu WL; Liu FC; Ho LJ
    Rheumatology (Oxford); 2011 Aug; 50(8):1379-89. PubMed ID: 21482542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.